article_metadata: Qingya Cui Peiqi Liang Haiping Dai Wei Cui Mengjie Cai Zixuan Ding Qinfen Ma Jia Yin Zheng Li Sining Liu Liqing Kang Li Yao Jiannong Cen Hongjie Shen Mingqing Zhu Lei Yu Depei Wu Xiaowen Tang
article_metadata: 10.3389/fimmu.2022.1012981
article_metadata: Front Immunol
article_metadata: 2022 Nov 29;13:1012981.
article_metadata: cd38 blast phase chimeric antigen receptor t cell chronic myeloid leukemia tyrosine kinase inhibitor
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36524116/
article_metadata: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Receptors, Chimeric Antigen / genetics Receptors, Chimeric Antigen / therapeutic use
article_metadata: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Receptors, Chimeric Antigen / genetics Receptors, Chimeric Antigen / therapeutic use Case Reports Research Support, Non-U.S. Gov't Cell- and Tissue-Based Therapy Drug Resistance, Neoplasm / genetics Humans Immunotherapy Protein Kinase Inhibitors / pharmacology Protein Kinase Inhibitors / therapeutic use Receptors, Chimeric Antigen Protein Kinase Inhibitors
article_metadata: PMC9744919
article_metadata: 36524116
article_metadata: Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase
article_metadata: 2022